Patient characteristics, donor-type, follow-up details
| Patient no. . | Disease . | Age, y . | Status at SCT . | Donor type . | Previous auto-SCT . | Follow-up, d . | Current status (d) . | Cause of death . |
|---|---|---|---|---|---|---|---|---|
| 1 | MM, asecretory | 56 | CR | MMUD | 2 | 420 | Dead; relapse (356) | Disease |
| 2 | MM, IgD | 44 | CR | MUD | 3 | 689 | Dead; relapse (404) | Disease |
| 3 | MM, IgA | 55 | PR | MSD | 2 | 486 | Dead | Multiorgan failure |
| 4 | MM, IgA | 55 | PR | MMUD | 2 | 691 | Alive; CR | NA |
| 5 | Ph+ ALL | 55 | 1st CR | MUD | 0 | 359 | Dead | Pneumonia |
| 6 | hg B-NHL | 29 | PR | MUD | 1 | 601 | Alive; CR | NA |
| 7 | Ph+ CML | 40 | 1st CP | MMUD | 0 | 563 | Alive; sec. graft loss (35) | NA |
| 8 | OMF | 47 | PD | MUD | 0 | 557 | Alive; CR | NA |
| 9 | MM, IgA | 46 | CR | MMUD | 2 | 473 | Alive; relapse (442) | NA |
| 10 | sAML | 56 | PD | MUD | 0 | 438 | Alive; relapse (413) | NA |
| 11 | MCL | 57 | PD | MUD | 1 | 403 | Alive; relapse (160) | NA |
| 12 | MM, IgG | 55 | PR | MUD | 1 | 382 | Alive; relapse (357) | NA |
| 13 | MM, IgG | 60 | PD | MUD | 2 | 90 | Dead; relapse (39) | Disease |
| 14 | CLL, Richter | 54 | PR | MSD | 0 | 356 | Alive; PR | NA |
| 15 | HD | 41 | PR | MUD | 1 | 354 | Alive; relapse (200) | NA |
| 16 | Ph+ ALL | 60 | CR | MSD | 0 | 115 | Dead | Sepsis |
| 17 | Ph+ CML | 55 | 1st CP | MUD | 0 | 270 | Alive; CR | NA |
| 18 | Follicular NHL | 57 | SD | MMUD | 1 | 245 | Alive; CR | NA |
| 19 | Follicular NHL | 59 | PR | MMUD | 2 | 216 | Alive; CR | NA |
| 20 | hg T-NHL | 41 | PD | MMUD | 1 | 216 | Alive; CR | NA |
| 21 | Pre T-ALL | 32 | PD | MUD | 0 | 130 | Dead; relapse (52) | Disease |
| 22 | AML | 60 | PD | MUD | 0 | 166 | Alive; CR | NA |
| 23 | MM, IgG | 55 | PR | MUD | 1 | 165 | Alive; CR | NA |
| Median | NA | 55 | NA | NA | NA | 359 | NA | NA |
| Patient no. . | Disease . | Age, y . | Status at SCT . | Donor type . | Previous auto-SCT . | Follow-up, d . | Current status (d) . | Cause of death . |
|---|---|---|---|---|---|---|---|---|
| 1 | MM, asecretory | 56 | CR | MMUD | 2 | 420 | Dead; relapse (356) | Disease |
| 2 | MM, IgD | 44 | CR | MUD | 3 | 689 | Dead; relapse (404) | Disease |
| 3 | MM, IgA | 55 | PR | MSD | 2 | 486 | Dead | Multiorgan failure |
| 4 | MM, IgA | 55 | PR | MMUD | 2 | 691 | Alive; CR | NA |
| 5 | Ph+ ALL | 55 | 1st CR | MUD | 0 | 359 | Dead | Pneumonia |
| 6 | hg B-NHL | 29 | PR | MUD | 1 | 601 | Alive; CR | NA |
| 7 | Ph+ CML | 40 | 1st CP | MMUD | 0 | 563 | Alive; sec. graft loss (35) | NA |
| 8 | OMF | 47 | PD | MUD | 0 | 557 | Alive; CR | NA |
| 9 | MM, IgA | 46 | CR | MMUD | 2 | 473 | Alive; relapse (442) | NA |
| 10 | sAML | 56 | PD | MUD | 0 | 438 | Alive; relapse (413) | NA |
| 11 | MCL | 57 | PD | MUD | 1 | 403 | Alive; relapse (160) | NA |
| 12 | MM, IgG | 55 | PR | MUD | 1 | 382 | Alive; relapse (357) | NA |
| 13 | MM, IgG | 60 | PD | MUD | 2 | 90 | Dead; relapse (39) | Disease |
| 14 | CLL, Richter | 54 | PR | MSD | 0 | 356 | Alive; PR | NA |
| 15 | HD | 41 | PR | MUD | 1 | 354 | Alive; relapse (200) | NA |
| 16 | Ph+ ALL | 60 | CR | MSD | 0 | 115 | Dead | Sepsis |
| 17 | Ph+ CML | 55 | 1st CP | MUD | 0 | 270 | Alive; CR | NA |
| 18 | Follicular NHL | 57 | SD | MMUD | 1 | 245 | Alive; CR | NA |
| 19 | Follicular NHL | 59 | PR | MMUD | 2 | 216 | Alive; CR | NA |
| 20 | hg T-NHL | 41 | PD | MMUD | 1 | 216 | Alive; CR | NA |
| 21 | Pre T-ALL | 32 | PD | MUD | 0 | 130 | Dead; relapse (52) | Disease |
| 22 | AML | 60 | PD | MUD | 0 | 166 | Alive; CR | NA |
| 23 | MM, IgG | 55 | PR | MUD | 1 | 165 | Alive; CR | NA |
| Median | NA | 55 | NA | NA | NA | 359 | NA | NA |
MM indicates multiple myeloma; CR, complete remission; MMUD, HLA-mismatched unrelated donor; MUD, HLA-matched unrelated donor; PR, partial remission; MSD, HLA-matched sibling donor; NA, not applicable; Ph+ ALL, Philadelphia chromosome-positive acute lymphoblastic leukemia; hg B-NHL, high-grade B-cell non-Hodgkin lymphoma; CML, chronic myeloid leukemia; CP, chronic phase; sec., secondary; OMF, osteomyelofibrosis; PD, progressive disease; sAML, secondary acute myeloid leukemia; MCL, mantle cell lymphoma; CLL, Richter, transformed chronic lymphocytic leukemia (Richter syndrome); HD, Hodgkin disease; SD, stable disease.